Hardy-Bessard, A., Pujade-Lauraine, E., Moore, R. G., Montestruc, F., Redondo, A., Mirza, M. R., Volodko, N., Ciuleanu, T., Gilbert, L., Eitan, R., Zagouri, F., Pignata, S., Glasspool, R., Pfisterer, J., Phaeton, R., Anderson, C. K., Rodrigues, M., Musa, F., Ray-Coquard, I. L., Moore, K. N. (2025). FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba5506